Market gives a big meh to presidential drug pricing orders

If any further proof were needed that the markets are not taking Donald Trump’s efforts to address drug pricing seriously, look no further than to today’s opening bell. No big pharma stocks showed any sign of reaction to the US president's attempts to lower patient out-of-pocket costs with four executive orders announced on Friday.